Coronary heart disease Acute coronary syndrome in human immunodeficiency virus-infected patients : characteristics and 1 year prognosis
暂无分享,去创建一个
D. Costagliola | P. Steg | K. Wahbi | F. Beygui | F. Boccara | E. Teiger | C. Funck-Brentano | M. Slama | M. Mary-Krause | P. Lim | P. Girard | S. Lang | O. Milleron | A. Cohen
[1] R. Napoli,et al. Human immunodeficiency virus per se exerts atherogenic effects. , 2009, Atherosclerosis.
[2] P. Morlat,et al. Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic) , 2008, Journal of acquired immune deficiency syndromes.
[3] Hang Lee,et al. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. , 2007, The Journal of clinical endocrinology and metabolism.
[4] H. Sørensen,et al. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] O. Kirk,et al. Class of antiretroviral drugs and the risk of myocardial infarction. , 2007, The New England journal of medicine.
[6] B. Strauss,et al. Outcome of percutaneous coronary intervention in HIV‐infected patients , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[7] J Darbyshire,et al. CD4+ count-guided interruption of antiretroviral treatment. , 2006, The New England journal of medicine.
[8] Jeffrey N. Martin,et al. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses , 2006, AIDS.
[9] John T Brooks,et al. Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study , 2006, Journal of acquired immune deficiency syndromes.
[10] J. Stein. Cardiovascular risk in patients with human immunodeficiency virus infection: incomplete data. , 2006, Journal of the American College of Cardiology.
[11] E. Di Angelantonio,et al. Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis , 2005, Heart.
[12] Á. Avezum,et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. , 2004, JAMA.
[13] D. Waters,et al. Clinical Features of Acute Coronary Syndromes in Patients With Human Immunodeficiency Virus Infection , 2004, Circulation.
[14] D. Costagliola,et al. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men , 2003, AIDS.
[15] J. Ambrose,et al. Frequency of and outcome of acute coronary syndromes in patients with human immunodeficiency virus infection. , 2003, The American journal of cardiology.
[16] D. Arveiler,et al. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] A. Simon,et al. Coronary artery disease in HIV infected patients , 2003, Intensive Care Medicine.
[18] S. Kaul,et al. Acute myocardial infarction in human immunodeficiency virus-infected patients. , 2003, Archives of internal medicine.
[19] J. Herlitz,et al. Ten year mortality in subsets of patients with an acute coronary syndrome , 2001, Heart.
[20] Hugo A. Katus,et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.
[21] S M Marcovina,et al. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. , 1999, Circulation.
[22] L. Fisher,et al. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). , 1995, Journal of the American College of Cardiology.
[23] E J Topol,et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. , 1990, Circulation.
[24] R. Hornung,et al. Ischemic cardiovascular disease in persons with human immunodeficiency virus infection. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.